Decreased DNA Methylation of RGMA is Associated with Intracranial Hypertension After Severe Traumatic Brain Injury : An Exploratory Epigenome-Wide Association Study
© 2022. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society..
BACKGROUND: Cerebral edema and intracranial hypertension are major contributors to unfavorable prognosis in traumatic brain injury (TBI). Local epigenetic changes, particularly in DNA methylation, may influence gene expression and thus host response/secondary injury after TBI. It remains unknown whether DNA methylation in the central nervous system is associated with cerebral edema severity or intracranial hypertension post TBI. We sought to identify epigenome-wide DNA methylation patterns associated with these forms of secondary injury after TBI.
METHODS: We obtained genome-wide DNA methylation profiles of DNA extracted from ventricular cerebrospinal fluid samples at three different postinjury time points from a prospective cohort of patients with severe TBI (n = 89 patients, 254 samples). Cerebral edema and intracranial pressure (ICP) measures were clustered to generate composite end points of cerebral edema and ICP severity. We performed an unbiased epigenome-wide association study (EWAS) to test associations between DNA methylation at 419,895 cytosine-phosphate-guanine (CpG) sites and cerebral edema/ICP severity categories. Given inflated p values, we conducted permutation tests for top CpG sites to filter out potential false discoveries.
RESULTS: Our data-driven hierarchical clustering across six cerebral edema and ICP measures identified two groups differing significantly in ICP based on the EWAS-identified CpG site cg22111818 in RGMA (Repulsive guidance molecule A, permutation p = 4.20 × 10-8). At 3-4 days post TBI, patients with severe intracranial hypertension had significantly lower levels of methylation at cg22111818.
CONCLUSIONS: We report a novel potential relationship between intracranial hypertension after TBI and an acute, nonsustained reduction in DNA methylation at cg22111818 in the RGMA gene. To our knowledge, this is the largest EWAS in severe TBI. Our findings are further strengthened by previous findings that RGMA modulates axonal repair in other central nervous system disorders, but a role in intracranial hypertension or TBI has not been previously identified. Additional work is warranted to validate and extend these findings, including assessment of its possible role in risk stratification, identification of novel druggable targets, and ultimately our ability to personalize therapy in TBI.
| Errataetall: |
CommentIn: Neurocrit Care. 2022 Aug;37(1):6-7. - PMID 35088301 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Neurocritical care - 37(2022), 1 vom: 13. Aug., Seite 26-37 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Liu, Dongjing [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
DNA methylation |
|---|
| Anmerkungen: |
Date Completed 18.07.2022 Date Revised 19.09.2023 published: Print-Electronic CommentIn: Neurocrit Care. 2022 Aug;37(1):6-7. - PMID 35088301 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12028-021-01424-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335637450 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335637450 | ||
| 003 | DE-627 | ||
| 005 | 20231225230313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12028-021-01424-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1118.xml |
| 035 | |a (DE-627)NLM335637450 | ||
| 035 | |a (NLM)35028889 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Liu, Dongjing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Decreased DNA Methylation of RGMA is Associated with Intracranial Hypertension After Severe Traumatic Brain Injury |b An Exploratory Epigenome-Wide Association Study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.07.2022 | ||
| 500 | |a Date Revised 19.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Neurocrit Care. 2022 Aug;37(1):6-7. - PMID 35088301 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society. | ||
| 520 | |a BACKGROUND: Cerebral edema and intracranial hypertension are major contributors to unfavorable prognosis in traumatic brain injury (TBI). Local epigenetic changes, particularly in DNA methylation, may influence gene expression and thus host response/secondary injury after TBI. It remains unknown whether DNA methylation in the central nervous system is associated with cerebral edema severity or intracranial hypertension post TBI. We sought to identify epigenome-wide DNA methylation patterns associated with these forms of secondary injury after TBI | ||
| 520 | |a METHODS: We obtained genome-wide DNA methylation profiles of DNA extracted from ventricular cerebrospinal fluid samples at three different postinjury time points from a prospective cohort of patients with severe TBI (n = 89 patients, 254 samples). Cerebral edema and intracranial pressure (ICP) measures were clustered to generate composite end points of cerebral edema and ICP severity. We performed an unbiased epigenome-wide association study (EWAS) to test associations between DNA methylation at 419,895 cytosine-phosphate-guanine (CpG) sites and cerebral edema/ICP severity categories. Given inflated p values, we conducted permutation tests for top CpG sites to filter out potential false discoveries | ||
| 520 | |a RESULTS: Our data-driven hierarchical clustering across six cerebral edema and ICP measures identified two groups differing significantly in ICP based on the EWAS-identified CpG site cg22111818 in RGMA (Repulsive guidance molecule A, permutation p = 4.20 × 10-8). At 3-4 days post TBI, patients with severe intracranial hypertension had significantly lower levels of methylation at cg22111818 | ||
| 520 | |a CONCLUSIONS: We report a novel potential relationship between intracranial hypertension after TBI and an acute, nonsustained reduction in DNA methylation at cg22111818 in the RGMA gene. To our knowledge, this is the largest EWAS in severe TBI. Our findings are further strengthened by previous findings that RGMA modulates axonal repair in other central nervous system disorders, but a role in intracranial hypertension or TBI has not been previously identified. Additional work is warranted to validate and extend these findings, including assessment of its possible role in risk stratification, identification of novel druggable targets, and ultimately our ability to personalize therapy in TBI | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a DNA methylation | |
| 650 | 4 | |a Epigenome-wide association study (EWAS) | |
| 650 | 4 | |a Intracranial hypertension | |
| 650 | 4 | |a Repulsive guidance molecule A (RGMA) | |
| 650 | 4 | |a Traumatic brain injury | |
| 700 | 1 | |a Zusman, Benjamin E |e verfasserin |4 aut | |
| 700 | 1 | |a Shaffer, John R |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Yunqi |e verfasserin |4 aut | |
| 700 | 1 | |a Arockiaraj, Annie I |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Shuwei |e verfasserin |4 aut | |
| 700 | 1 | |a Weeks, Daniel E |e verfasserin |4 aut | |
| 700 | 1 | |a Desai, Shashvat M |e verfasserin |4 aut | |
| 700 | 1 | |a Kochanek, Patrick M |e verfasserin |4 aut | |
| 700 | 1 | |a Puccio, Ava M |e verfasserin |4 aut | |
| 700 | 1 | |a Okonkwo, David O |e verfasserin |4 aut | |
| 700 | 1 | |a Conley, Yvette P |e verfasserin |4 aut | |
| 700 | 1 | |a Jha, Ruchira M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurocritical care |d 2004 |g 37(2022), 1 vom: 13. Aug., Seite 26-37 |w (DE-627)NLM157737888 |x 1556-0961 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2022 |g number:1 |g day:13 |g month:08 |g pages:26-37 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12028-021-01424-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2022 |e 1 |b 13 |c 08 |h 26-37 | ||